Pay in 4 interest-free payments of $31.24 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Smiles: CN(C)C1NC2=C(N=1)C(Br)=C(Br)C(Br)=C2Br
2ClH/c17-19(18
YS 49 induced HO-1 protein production in a dose-and time-dependent manner in VSMCs
3-benzodiazol-1-yl}-5-(hydroxymethyl)oxolane-3
1016/B978-0-12-800173-8
TAK-438 - CAS# 881681-01-2 Size:Solid 10 mg Smiles: CN(C)C1NC2=C(N=1)C(Br)=C(Br)C(Br)=C2BrTAK438, also known as Vonoprazan Fumarate, is a new medicine for treating acid related diseases with a novel mechanism of action called potassium competitive acid blockers (P CABs) which competitively inhibits the binding of potassium ions to H+, K+ ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal cells. TAKECAB provides a strong and sustained acid secretion inhibitory effect. Product information
US$ 280.25
US$ 129.95
US$ 150.25
US$ 145.50
US$ 14.00
US$ 254.97
US$ 104.97
US$ 45.00
US$ 439.98
US$ 124.95
US$ 29.00
US$ 145.50
US$ 109.95
US$ 44.95
US$ 11.00
US$ 246.25